Focal cerebral ischemia and traumatic brain injury induce an escalating amount of cell death because of harmful mediators diffusing from the original lesion site. Evidence suggests that healthy cells surrounding these lesions attempt to protect themselves by producing endocannabinoids (eCBs) and activating cannabinoid receptors, the molecular target for marijuana-derived compounds. Indeed, activation of cannabinoid receptors reduces the production and diffusion of harmful mediators. Here, we provide evidence that an exception to this pattern is found in experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis. We show that cell damage induced by EAE does not lead to increase in eCBs, even though cannabinoid receptors are functional because synthetic cannabinoid agonists are known to confine EAE-induced lesions. This lack of eCB increase is likely due to IFN-␥, which is released by primed T cells invading the CNS. We show that IFN-␥ disrupts the functionality of purinergic P2X7 receptors, a key step controlling eCB production by microglia, the main source of eCBs in brain. Accordingly, induction of EAE in P2X 7 ؊/؊ mice results in even lower eCB levels and more pronounced cell damage than in wild-type mice. Our data suggest that the high level of CNS IFN-␥ associated with EAE disrupts eCBmediated neuroprotection while maintaining functional cannabinoid receptors, thus providing additional support for the use of cannabinoid-based medicine to treat multiple sclerosis.cannabinoid ͉ microglia ͉ purinergic ͉ multiple sclerosis P hysiological stimuli and pathological conditions lead to differential increases in brain endocannabinoids (eCBs) that regulate distinct biological functions. Physiological stimuli lead to rapid and transient (seconds to minutes) increases in eCBs that activate neuronal CB 1 receptors, modulate ion channels, and inhibit neurotransmission (1), whereas pathological conditions lead to much slower and sustained (hours to days) increases in the eCB tone that change gene expression, implementing molecular mechanisms that prevent the production and diffusion of harmful mediators (2-9). Specifically, increases in the eCB tone activate immune CB 2 receptors, which reduce the expression of proinflammatory cytokines and enzymes involved in the generation of free radicals, and neuronal CB 1 receptors, thereby increasing the expression of growth factors. Although we are starting to understand how sustained increases in eCB tone and corresponding activation of cannabinoid receptors implement a protective mechanism to confine lesions, we still lack essential information on the molecular mechanism controlling the brain's eCB tone.
ResultsNeuropathologies of different etiologies are all associated with increases in eCB tone (2,3,8,10,11), suggesting that cell damage itself may initiate this response. In previous studies, we showed that activation of purinergic P2X 7 receptors increases the production of the most abundant eCB, 2-arachidonoylglycerol (2-AG), from microglia and that the...